United BioSource Corporation Announces Acquisition of Cognitive Drug Research, Ltd. to Advance Services in Cognitive Testing in Clinical Research

* Leader in cognition measurement integrates into UBC to maximize measurement
precision of pivotal endpoints and ensure data integrity.

BETHESDA, Md.--(Business Wire)--
United BioSource Corporation (UBC) today announced the acquisition of Cognitive
Drug Research, Ltd. (CDR), the leader in computerized cognitive testing for
clinical trials. The CDR System is the most widely used computerized cognitive
testing system in the world: it is used in more than 1000 trials encompassing
approximately 50 different disease areas, validated in over 60 languages, and
cited in more than 700 publications and abstracts. Additionally, CDR maintains
the industry`s largest healthy subject, patient, and drug databases of cognitive
effects, providing the standard for establishing the clinical relevance of
compounds.

Computerized cognitive testing facilitates standardized administration,
measurement precision, and the reliability of cognitive endpoints. Importantly,
it enables the assessment of major aspects of cognitive function that are
otherwise overlooked by traditional methods. The CDR System has demonstrated
unparalleled sensitivity to cognitive enhancements as well as to impairments in
a broad range of disorders. Increased sensitivity translates into significant
cost savings as fewer study subjects are required to reach statistical
significance.

"Our experience with both computerized cognitive testing and the measurement of
clinician- and patient-reported outcomes has reinforced the need for a fully
integrated solution to reliably assess cognitive function," said Catherine
Spear, Sr. Vice President at UBC. "CDR offers a solution no one else in the
industry can provide; more than 20 years of clinical trial experience together
with the largest, most comprehensive cognitive effects database encompassing
tens of thousands of patients."

"The premier evidence base, reliability, and global reach of the CDR System
coupled with UBC`s validated rater training, assessment, and rater surveillance
methods will provide an unprecedented opportunity for improved signal detection
in the measurement of cognition and clinically subjective endpoints," said Ethan
Leder, CEO of UBC. "The addition of Professor Keith Wesnes, to the UBC
scientific team and our integrated offerings will provide sponsor companies with
the broadest, most seamless capabilities available."

"We are excited to join the UBC family and take cognitive testing to the next
level," said Professor Keith Wesnes, Chief Executive and founder of CDR.
"Combining the CDR System with UBC`s industry-leading solutions for
standardizing the administration and scoring of clinically subjective outcomes
measures offers pharmaceutical and medical device companies the unique ability
to cost-effectively integrate computerized cognitive testing, rater training,
and data quality monitoring to generate accurate, clinically relevant data in
even the very largest, most complex development programs," stated Professor
Wesnes.

About Cognitive Drug Research

CDR is the world leader in automated cognitive function assessment in phase I
through phase IV clinical trials. Founded by Keith Wesnes in 1986, CDR`s
proprietary cognitive assessment system can be administered to virtually any
patient population in any environment and provides rapid, sensitive, and highly
reliable assessments of the core domains of cognitive function. The CDR System
is used throughout the drug development process, from first-in-man trials to
large worldwide phase IV trials. The CDR System has been used in more than 1000
trials, and is documented to ICH GCP and FDA 21 CFR part 11 standards.

About United BioSource Corporation

UBC accelerates the generation, analysis, and communication of real-world
evidence by integrating scientific and operational expertise with innovative
technology solutions to support global development and commercialization of
medical products for life science companies.

The company is headquartered in Bethesda, Maryland, with offices located in the
United States, Canada, Europe, Latin America, and Japan. For more information
about UBC, visit www.unitedbiosource.com.

For a fact sheet on CDR please visit
http://unitedbiosource.com/news/press-releases.aspx.

United BioSource Corporation (UBC)
Adam Butler, +1 610-225-5900
info@unitedbiosource.com

Copyright Business Wire 2009